Innovotech Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
827.30
209.60
250.60
215.50
753.40
127.60
Depreciation, Depletion & Amortization
55.20
49.80
42.70
19.40
16.80
15.40
Other Funds
45.60
-
-
-
160.00
8.70
Funds from Operations
641.90
79.40
129.20
102.30
53.10
121
Changes in Working Capital
80.90
14.70
156.80
114.60
114.40
160.40
Net Operating Cash Flow
561.00
94.00
27.60
12.30
167.50
281.40
Capital Expenditures
7.40
-
-
-
13.70
Sale of Fixed Assets & Businesses
-
-
-
4.00
2.10
Net Investing Cash Flow
7.40
-
-
4.00
11.60
Issuance/Reduction of Debt, Net
50.00
61.70
-
9.00
-
Net Financing Cash Flow
158.00
61.70
-
9.00
470.40
Net Change in Cash
410.30
32.30
27.60
0.70
291.40
Free Cash Flow
568.40
94.00
27.70
12.30
181.20
Change in Capital Stock
153.70
-
-
-
630.40

About Innovotech

View Profile
Address
2011-94th Street
Edmonton Alberta T6N 1H1
Canada
Employees -
Website http://www.innovotech.ca
Updated 07/08/2019
Innovotech, Inc. engages in the development and provision of solutions for medical, agricultural and industrial problems caused by microbial biofilms. Its products include the MBEC Assay, InnovoSIL, various coatings of MBEC Lids, and Agress & AgreGuard. The company was founded by Merle Olson and Howard Ceri on January 31, 2001 and is headquartered in Edmonton, CA.